What is CHRO stock price today?

Visit our real-time dashboard for the current CHRO stock price and live market data.

Is CHRO stock going up or down today?

CHRO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CHRO stock now?

The decision to buy CHRO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CHRO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CHRO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CHRO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CHRO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CHRO's P/E ratio?

P/E ratio data for CHRO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CHRO's market cap?

CHRO (Chromocell Therapeutics Corporation) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is CHRO's price to book ratio?

Price-to-book ratio for CHRO is available on our dashboard along with other valuation metrics.

Does CHRO pay dividends?

CHRO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CHRO's dividend yield?

CHRO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CHRO stock a good long-term investment?

CHRO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CHRO's revenue growth rate?

Revenue growth data for CHRO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CHRO are available on our dashboard with complete income statement analysis.

What are the risks of investing in CHRO?

Key risks for CHRO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CHRO compare to its competitors?

Compare CHRO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHRO's performance and positioning.

What is CHRO's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CHRO with bull, base, and bear case scenarios.

What do analysts say about CHRO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHRO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CHRO's next earnings report?

CHRO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CHRO - Chromocell Therapeutics Corporation

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Chromocell Therapeutics Corporation

Chromocell Therapeutics Corporation (CHRO) common stock

Price Chart

Loading chart...

CHRO Key Statistics

Market Cap

$8.90M

How CHRO Compares to Peers

CHRO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
CHRO(This stock)	$8.90M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 9, 2026 at 6:34 PM EDT

Ready to invest in CHRO?

Commission-free trading available. Affiliate links.

Upcoming Events for CHRO

Dashboard

Enter a ticker to analyze